The life sciences segment is focusing on quicker monetization opportunities due to market challenges. Mobile solutions see growth from share gains, not destocking. Price realization is expected to continue with balanced costs. Off-road segment recovery is uncertain.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing